Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by hopper_1on Jan 19, 2019 5:32pm
91 Views
Post# 29256045

RE:RE:Is Pharmacielo a takeover target or an ennemy to ACB?

RE:RE:Is Pharmacielo a takeover target or an ennemy to ACB? This is from there web site sounds like another Sino-Forest. 15 Million square feet of available cultivation capacity *1 PharmaCielo received its Colombian manufacturing licence in 2016 and has rapidly become the dominant player in Colombias rapidly growing legal cannabis sector. The company is licensed to produce both CBD-dominant and THC-dominant cannabis under quota from the Colombian government. The company was the first Colombian recipient of a licence to cultivate THC-dominant strains and produce THC-focused cannabis oil extracts. *1 15 million square feet comprised of: 1.3 million-square-foot nursery & propagation centre (Company-owned), 0.4 million square feet of open-air greenhouses owned by the Company with indigenous growers and 13.3 million square feet of open-air greenhouse capacity accessed through contract growers.
Bullboard Posts